medical device investing A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
medical device investing A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
medical device investing Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
medical device investing Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
medical device investing Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
medical device investing Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
medical device investing Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
medical device investing CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
medical device investing Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference
medical device investing Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
medical device investing Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions
EnerCom Announces SM Energy as a Keynote Speaker at the 31st EnerCom Denver - The Energy Investment Conference, on August 19, 2026, in Denver, Colorado
